Cite
MRI Imaging of the Hemodynamic Vasculature of Neuroblastoma Predicts Response to Antiangiogenic Treatment.
MLA
Zormpas-Petridis, Konstantinos, et al. “MRI Imaging of the Hemodynamic Vasculature of Neuroblastoma Predicts Response to Antiangiogenic Treatment.” Cancer Research, vol. 79, no. 11, June 2019, pp. 2978–91. EBSCOhost, https://doi.org/10.1158/0008-5472.CAN-18-3412.
APA
Zormpas-Petridis, K., Jerome, N. P., Blackledge, M. D., Carceller, F., Poon, E., Clarke, M., McErlean, C. M., Barone, G., Koers, A., Vaidya, S. J., Marshall, L. V., Pearson, A. D. J., Moreno, L., Anderson, J., Sebire, N., McHugh, K., Koh, D.-M., Yuan, Y., Chesler, L., … Jamin, Y. (2019). MRI Imaging of the Hemodynamic Vasculature of Neuroblastoma Predicts Response to Antiangiogenic Treatment. Cancer Research, 79(11), 2978–2991. https://doi.org/10.1158/0008-5472.CAN-18-3412
Chicago
Zormpas-Petridis, Konstantinos, Neil P Jerome, Matthew D Blackledge, Fernando Carceller, Evon Poon, Matthew Clarke, Ciara M McErlean, et al. 2019. “MRI Imaging of the Hemodynamic Vasculature of Neuroblastoma Predicts Response to Antiangiogenic Treatment.” Cancer Research 79 (11): 2978–91. doi:10.1158/0008-5472.CAN-18-3412.